Six Million Enrolled in New Medicare+Choice Plans

Publication
Article
Oncology NEWS InternationalOncology NEWS International Vol 8 No 4
Volume 8
Issue 4

WASHINGTON-At the beginning of 1999, more than 6 million of Medicare’s 40 million beneficiaries were enrolled in some 300 Medicare+Choice plans, the new managed care program instituted by the Health Care Financing Administration (HCFA). The move to Medicare+Choice was not without disruption, as health care organizations covering 400,000 Medicare recipients refused to renew their contracts with HCFA under the new payment arrangement.

WASHINGTON—At the beginning of 1999, more than 6 million of Medicare’s 40 million beneficiaries were enrolled in some 300 Medicare+Choice plans, the new managed care program instituted by the Health Care Financing Administration (HCFA). The move to Medicare+Choice was not without disruption, as health care organizations covering 400,000 Medicare recipients refused to renew their contracts with HCFA under the new payment arrangement.

In the year 2000, payments for patients enrolled in Medicare+Choice plans will be determined by a combination of local and national rates, which will be adjusted to reflect the relative health status of the enrollees.

Recent Videos
Brett L. Ecker, MD, focused on the use of de-escalation therapy, which is gaining momentum in neuroendocrine tumors.
Immunotherapy options like CAR T-cell therapy and antigen-presenting cell-directed agents are currently being evaluated in the pancreatic cancer field.
Certain bridging therapies and abundant steroid use may complicate the T-cell collection process during CAR T therapy.
Pancreatic cancer is projected to become the second-leading cause of cancer-related deaths by 2030 in the United States.
2 experts are featured in this video
2 experts are featured in this video
2 experts are featured in this video
4 KOLs are featured in this series.
Related Content